Thomas Alexander
0000-0002-0484-1574
6 papers found
Refreshing results…
The role of relative advantage for development of sequencing‐based diagnostics for pediatric cancer in low‐ and middle‐income countries
Bilineal evolution of a U2AF1-mutated clone associated with acquisition of distinct secondary mutations
Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Genomic subtyping and therapeutic targeting of acute erythroleukemia
Decreased relapsed rate and treatment‐related mortality contribute to improved outcomes for pediatric acute myeloid leukemia in successive clinical trials
Opportunities for expanding clinical trial enrollment for relapsed and refractory pediatric acute myeloid leukemia in the United States and Canada
Missing publications? Search for publications with a matching author name.